Drugs / VK4-116
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06808932 | Aug 2026 → Apr 2027 expected | opiate dependence | National Institute on Drug Abuse (NIDA) | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VK4-116 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06808932 ↗ |
| Route | Oral | “oral administration in fasted state” NCT06808932 ↗ |